Medtronic
MDT | NYSE
$98.39
+$1.85 (+1.92%)
Nov 2, 2026, 12:15 PM ET · Market open
Company Profile
Medtronic plc is a leading global medical technology enterprise that invents, develops, manufactures, and distributes an extensive range of device-based medical therapies. These solutions serve healthcare systems, clinicians, physicians, and patients across the world. The company's operations are categorized into several key portfolios: Cardiovascular Portfolio: This segment focuses on cardiac health, providing technologies for heart rhythm management, including implantable pacemakers, defibrillators, and monitoring systems, alongside cardiac ablation tools and remote patient software. It also addresses structural heart issues with products like aortic and pulmonary valves, surgical repair devices, and endovascular stent grafts, in addition to offerings for percutaneous coronary interventions (e.g., angioplasty balloons). Medical Surgical Portfolio: Offering a broad spectrum of surgical instruments and therapies, this division includes staples, vessel sealing devices, wound closure products, and electrosurgical equipment. It also pioneers surgical artificial intelligence and robotic-assisted platforms, alongside solutions for hernia repair, gynecology, lung conditions, minimally invasive gastrointestinal and hepatologic diagnostics, patient monitoring, airway management, ventilation therapies, and renal disease. Neuroscience Portfolio: This division delivers specialized products for a diverse group of medical professionals, such as spinal surgeons, neurosurgeons, neurologists, pain management specialists, and ENT experts. Its offerings span energy surgical instruments, advanced image-guided and intra-operative imaging systems, robotic guidance for spine procedures, and therapies targeting the brain's vasculature. Diabetes Operating Unit: Dedicated to diabetes management, this unit provides innovative solutions like insulin pumps and their associated consumables, continuous glucose monitoring (CGM) systems, and smart insulin pen technologies. Established in 1949, Medtronic plc maintains its corporate headquarters in Dublin, Ireland.
Key Executives
| Name | Position |
|---|---|
| Geoffrey Straub Martha | Chairman of the Board & Chief Executive Officer |
| Thierry Pieton | Executive Vice President & Chief Financial Officer |
| Alan Cheng | Chief Medical Officer of Cardiac Rhythm Management |
| Alex Gu | Senior VP & President of Greater China Region |
| Austin L. Chiang | Chief Medical Officer Gastrointestinal Business |
| Brett A. Wall | Executive Officer |
| Dave Moeller | Senior VP & President of the Peripheral Vascular Health Operating Unit |
| Denise L. Blomquist | Vice President, Global Controller & Chief Accounting Officer |
| Harry Kiil | Executive Vice President & President of Cardiovascular Portfolio |
| Ingrid Goldberg | Vice President & Head of Investor Relations |
| Jason Weidman | Senior VP and President of Coronary & Renal Denervation business |
| Kweli Thompson | Executive Vice President & President of Neuroscience Portfolio |
| Laura Mauri | Senior Vice President and Chief Scientific & Medical Officer |
| Linnea Burman | Senior VP and President of Medtronic's Neurovascular business |
| Matthew Walter | Senior Vice President of Human Resources, IT and Global Communications & Corporate Marketing |
| Michael Marinaro | Executive VP and President of Medical Surgical Portfolio & Americas |
| Michelle Quinn | Executive Vice President, General Counsel & Secretary |
| Robert Adam Hopkins | Senior Vice President & Head of Global Strategy |
| Robert Kowal | VP & GM of Cardiac Pacing Therapies |
| Rogerio Branco | SVP & Chief Operations and Supply Chain Officer |
| Sally Saba | Chief Inclusion & Diversity Officer |
Medtronic
| Country | Ireland |
| IPO Date | May 2, 1973 |
| Industry | Medical - Devices |
| Sector | Healthcare |
| Employees | 95,000 |
| CEO | Geoffrey Straub Martha |
Contact Details
Building Two, Parkmore Business Park West Galway,
Georgia H91 4K49 Ireland
Stock Details
| Ticker Symbol | MDT |
| Exchange | NYSE |
| Fiscal Year | May - April |
| Reporting Currency | USD |
| CIK Code | 0001613103 |
| CUSIP Number | G5960L103 |
| ISIN Number | IE00BTN1Y115 |
| SIC Code | 3845 |
Recent News
- 1 day ago / fool.comMedtronic Just Retired 55 Million Shares Without Spending Cash. Is the Stock a Buy?
- 3 days ago / zacks.comWhy the Market Dipped But Medtronic (MDT) Gained Today
- 6 days ago / 247wallst.comMedtronic Has Raised Its Dividend for 49 Years. These 2 Rivals Have Even Longer Streaks
- 6 days ago / 247wallst.comMedtronic Quietly Raised Its Dividend Again. Is It a Buy for Income Investors?
- 11 days ago / gurufocus.comA Look at Medtronic PLC (MDT) After 3.8% Gain -- GF Value $101.17 vs Price $96.59
- 11 days ago / prnewswire.comMedtronic announces positive results from real-world registries for the Sphere-9™ catheter and PulseSelect™ PFA System at APHRS 2026
- 14 days ago / zacks.comMedtronic (MDT) Stock Dips While Market Gains: Key Facts
- 16 days ago / fool.comHow Many Shares Would It Take to Earn $1,000 a Year From This Future Dividend King?
- 17 days ago / zacks.comIs it Apt to Retain Medtronic Stock in Your Portfolio Now?
- 18 days ago / prnewswire.comMedtronic Named to TIME Best Inventions of 2026 List for Stealth AXiS™ surgical system and Corsano™* multi-parameter wearable
Add to Watchlist
Select watchlists to add or remove MDT